Summary of Purpose
To test the safety and potential improvement in neurological recovery of acute ischemic stroke patients treated with mild hypervolemic hemodilution (HHD) with low substituted 10% hydroxyethyl starch (HES) compared to pure rehydration with crystalloid fluid .Read More →
The following dates are available for this trial. Trial information last updated on 31 October 2000.
|Start Date||First Received||1st Completion||Completion||Verification||Results|
Randomized, double-blind, placebo-controlled study of 200 patients at 15 Austrian hospitals.
Franz T. Aichner, MD, Department of Neurology and Magnetic Resonance, University Hospital, Anichstraße 35, 6020 Innsbruck, Austria.firstname.lastname@example.org